West Pharmaceutical Services (WST) Return on Invested Capital (2010 - 2024)

West Pharmaceutical Services (WST) has reported Return on Invested Capital for 15 consecutive years, with 1.48% the latest figure, recorded in Q2 2024.

• Quarterly Return on Invested Capital rose 67.0% year-over-year to 1.48% in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 1.48% (up 67.0% YoY) and the FY2021 annual result came in at 0.28%, down 117.0% from the prior year.
• Return on Invested Capital advanced to 1.48% in Q2 2024 per WST's latest filing, from 0.97% in the prior quarter.
• Over the last five years, Return on Invested Capital for WST reached as high as 1.48% in Q2 2024 and fell as low as 0.07% in Q1 2022.
• A 5-year average of 0.53% and a median of 0.46% in 2020 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2020 — Return on Invested Capital plunged 2223 bps — and 2023, when it jumped 80 bps.
• Year by year, Return on Invested Capital stood at 0.36% in 2020, then tumbled by 75 bps to 0.09% in 2021, then jumped by 138 bps to 0.21% in 2022, then soared by 297 bps to 0.84% in 2023, then surged by 75 bps to 1.48% in 2024.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 1.48%, 0.97%, and 0.84% for Q2 2024, Q1 2024, and Q4 2023 respectively.